BR112022022322A2 - Compostos de metiltionínio para uso no tratamento de hipoxemia - Google Patents
Compostos de metiltionínio para uso no tratamento de hipoxemiaInfo
- Publication number
- BR112022022322A2 BR112022022322A2 BR112022022322A BR112022022322A BR112022022322A2 BR 112022022322 A2 BR112022022322 A2 BR 112022022322A2 BR 112022022322 A BR112022022322 A BR 112022022322A BR 112022022322 A BR112022022322 A BR 112022022322A BR 112022022322 A2 BR112022022322 A2 BR 112022022322A2
- Authority
- BR
- Brazil
- Prior art keywords
- hypoxemia
- methylthionium
- compounds
- treatment
- methylthioninium
- Prior art date
Links
- 206010021143 Hypoxia Diseases 0.000 title abstract 3
- 208000018875 hypoxemia Diseases 0.000 title abstract 3
- 150000001875 compounds Chemical class 0.000 title abstract 2
- -1 methylthioninium Compound Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Abstract
COMPOSTOS DE METILTIONÍNIO PARA USO NO TRATAMENTO DE HIPOXEMIA. A presente invenção se refere a métodos para aliviar a hipoxemia em um indivíduo através da administração oral de um composto de metiltionínio.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB2006659.3A GB202006659D0 (en) | 2020-05-05 | 2020-05-05 | Therapeutic treatments |
GBGB2016957.9A GB202016957D0 (en) | 2020-10-26 | 2020-10-26 | Beneficial treatment |
PCT/EP2021/061485 WO2021224146A1 (en) | 2020-05-05 | 2021-04-30 | Methylthioninium compounds for use in the treatment of hypoxemia |
Publications (1)
Publication Number | Publication Date |
---|---|
BR112022022322A2 true BR112022022322A2 (pt) | 2022-12-13 |
Family
ID=75887990
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112022022322A BR112022022322A2 (pt) | 2020-05-05 | 2021-04-30 | Compostos de metiltionínio para uso no tratamento de hipoxemia |
Country Status (11)
Country | Link |
---|---|
US (1) | US20230158040A1 (pt) |
EP (1) | EP4146225A1 (pt) |
JP (1) | JP2023524146A (pt) |
KR (1) | KR20230012515A (pt) |
CN (1) | CN115916211A (pt) |
AU (1) | AU2021268465A1 (pt) |
BR (1) | BR112022022322A2 (pt) |
CA (1) | CA3181388A1 (pt) |
MX (1) | MX2022013884A (pt) |
TW (1) | TW202200149A (pt) |
WO (1) | WO2021224146A1 (pt) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB202204185D0 (en) | 2022-03-24 | 2022-05-11 | Wista Lab Ltd | Oral treatment |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0017060D0 (en) * | 2000-07-11 | 2000-08-30 | Hunter Fleming Ltd | Production, stabilisation and use of reduced forms of pharmaceutical compounds |
US20060264423A1 (en) | 2005-05-20 | 2006-11-23 | Bioenvision, Inc. | Methylene Blue Therapy of Viral Disease |
CN104119294B (zh) | 2006-03-29 | 2018-10-30 | 维斯塔实验室有限公司 | 3,7-二氨基-10h-吩噻嗪化合物的制备方法 |
SI2673266T1 (sl) * | 2011-02-11 | 2016-11-30 | Wista Laboratories Ltd. | Fenotiazin diaminijeve soli in njihova uporaba |
MY201804A (en) * | 2016-07-25 | 2024-03-19 | Wista Laboratories Ltd | Administration and dosage of diaminophenothiazines |
AU2019308873A1 (en) * | 2018-07-26 | 2021-02-04 | Wista Laboratories Ltd. | Optimised dosage of diaminophenothiazines in populations |
EP3982974A4 (en) * | 2019-06-12 | 2023-06-21 | Achal Narendrakumar Agrawal | NOVEL IMPROVED PROCESS FOR THE SYNTHESIS OF DIAMINOPHENOTHIAZINE COMPOUNDS |
-
2021
- 2021-04-30 CN CN202180043776.XA patent/CN115916211A/zh active Pending
- 2021-04-30 AU AU2021268465A patent/AU2021268465A1/en active Pending
- 2021-04-30 MX MX2022013884A patent/MX2022013884A/es unknown
- 2021-04-30 WO PCT/EP2021/061485 patent/WO2021224146A1/en unknown
- 2021-04-30 EP EP21724580.2A patent/EP4146225A1/en active Pending
- 2021-04-30 BR BR112022022322A patent/BR112022022322A2/pt not_active Application Discontinuation
- 2021-04-30 US US17/922,886 patent/US20230158040A1/en active Pending
- 2021-04-30 CA CA3181388A patent/CA3181388A1/en active Pending
- 2021-04-30 KR KR1020227042296A patent/KR20230012515A/ko unknown
- 2021-04-30 JP JP2022567338A patent/JP2023524146A/ja active Pending
- 2021-05-05 TW TW110116178A patent/TW202200149A/zh unknown
Also Published As
Publication number | Publication date |
---|---|
KR20230012515A (ko) | 2023-01-26 |
MX2022013884A (es) | 2022-11-30 |
CN115916211A (zh) | 2023-04-04 |
CA3181388A1 (en) | 2021-11-11 |
AU2021268465A1 (en) | 2022-12-08 |
TW202200149A (zh) | 2022-01-01 |
JP2023524146A (ja) | 2023-06-08 |
US20230158040A1 (en) | 2023-05-25 |
EP4146225A1 (en) | 2023-03-15 |
WO2021224146A1 (en) | 2021-11-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA202102544B (en) | Ligand-drug conjugate of exatecan analogue, preparation method therefor and application thereof | |
EA201690223A1 (ru) | Ингибиторы фактора в комплемента на основе производных пиперидинилиндола и их применение | |
UY32156A (es) | Derivados sustituidos de la n2 - [1-(5 - fluoropirimidin -2-il) etil] - n4 - (1-metil - 1h-imidazol - 4 - il)) - pirimidina - 2,4 - diaminas y sus sales farmacéuticamente aceptables, proceso de preparación, composiciones conteniéndolos y aplicaciones. | |
BR112015023153A2 (pt) | utilização de um composto e composto | |
NZ744567A (en) | Treatment of cancers using pi3 kinase isoform modulators | |
BR112021006458A2 (pt) | composto de isoindolina, seu método de preparação, composição farmacêutica e uso | |
ECSP14013325A (es) | Piridopirazinas anticancerigenas via la inhibicion de cinasas del receptor del factor de crecimiento de fibroblasto (fgfr) | |
EA201491362A1 (ru) | Анестезирующие соединения и способы их применения | |
BR112015020941A2 (pt) | uso de derivados de pirazolopirimidina para o tratamento de distúrbios relacionados a pi3kdelta | |
MA37866A1 (fr) | Dérivés de type aza-indazole ou diaza-indazole pour le traitement de la douleur | |
UY32174A (es) | Nuevos heterociclos sustituidos, composiciones farmaceuticas conteniendolos, procedimientos de preparacion y aplicaciones | |
UY31065A1 (es) | Heterociclos ciclicos | |
MX2013012588A (es) | Inhibidores de cinasa. | |
UY31885A (es) | Derivados de las 1, 3, 5-triazina-2, 4-diaminas-6-sustituidas-n-sustituidas y sales farmacéuticamente aceptables de los mismos, composiciones y aplicaciones. | |
GEP20166444B (en) | Epoxyeicosatrienoic acid analogs and methods of making and using the same | |
BR112014001083B8 (pt) | Composto, processo para a preparação de um composto, composição farmacêutica, uso da composiçâo farmacêutica e uso do composto | |
PH12014502547A1 (en) | Dosage regimen for a pi-3 kinase inhibitor | |
AR101674A1 (es) | Uso de un compuesto tricíclico que contiene nitrógeno | |
NZ706591A (en) | Oxazolidin-2-one-pyrimidine derivatives | |
BR112017026272A2 (pt) | ?composto, composição farmacêutica, método para o tratamento de uma desordem relacionada a receptor m1 muscarínico e uso do composto? | |
UY32055A (es) | Derivados sustituidos de la 5-Halo-N2-[sustituido](1-metil-1H-imidazol-4-il)pirimidin-2,-diamina y sus sales farmacéuticamente aceptables, procesos de preparación, composiciones y aplicaciones. | |
BR112022022322A2 (pt) | Compostos de metiltionínio para uso no tratamento de hipoxemia | |
BR112016008060A8 (pt) | composto, formulação farmacêutica, processo para preparar um composto de fórmula (i), método para preparação de um composto, uso do composto ou sal farmaceuticamente aceitável do mesmo | |
BR112013026933A2 (pt) | uso de uma combinação de pelo menos um carotenoide | |
BR112013025610A2 (pt) | uso de um metapneumovírus aviário vivo, e, composição farmacêutica |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B09B | Patent application refused [chapter 9.2 patent gazette] | ||
B12B | Appeal against refusal [chapter 12.2 patent gazette] |